rel-2, 5-Dioxopyrrolidin-1-yl 1-((1R, 8S, 9s)-bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2, 7, 10, 13, 16-pentaoxa-4-azanonadecan-19-oate

Modify Date: 2025-08-23 08:48:58

rel-2, 5-Dioxopyrrolidin-1-yl 1-((1R, 8S, 9s)-bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2, 7, 10, 13, 16-pentaoxa-4-azanonadecan-19-oate Structure
rel-2, 5-Dioxopyrrolidin-1-yl 1-((1R, 8S, 9s)-bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2, 7, 10, 13, 16-pentaoxa-4-azanonadecan-19-oate structure
Common Name rel-2, 5-Dioxopyrrolidin-1-yl 1-((1R, 8S, 9s)-bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2, 7, 10, 13, 16-pentaoxa-4-azanonadecan-19-oate
CAS Number 1702356-19-1 Molecular Weight 538.59
Density 1.28±0.1 g/cm3(Predicted) Boiling Point N/A
Molecular Formula C26H38N2O10 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of rel-2, 5-Dioxopyrrolidin-1-yl 1-((1R, 8S, 9s)-bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2, 7, 10, 13, 16-pentaoxa-4-azanonadecan-19-oate


BCN-endo-PEG4-NHS is an ADC Linker containing 4 PEG units. BCN-endo-PEG4-NHS contains the lyophilic bidentate macrocyclic ligand endo-BCN, which allows for further synthesis of macrocyclic complexes. In click chemistry, endo-BCN can react with molecules containing azide groups to form stable triazoles in the absence of catalysts.

 Names

Name ENdo-BCN-PEG4-NHS ester
Synonym More Synonyms

  Biological Activity

Description BCN-endo-PEG4-NHS is an ADC Linker containing 4 PEG units. BCN-endo-PEG4-NHS contains the lyophilic bidentate macrocyclic ligand endo-BCN, which allows for further synthesis of macrocyclic complexes. In click chemistry, endo-BCN can react with molecules containing azide groups to form stable triazoles in the absence of catalysts.
Related Catalog

 Chemical & Physical Properties

Density 1.28±0.1 g/cm3(Predicted)
Molecular Formula C26H38N2O10
Molecular Weight 538.59

 Safety Information

Hazard Codes Xn

 Synonyms

MFCD23704191
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.